Registered Kenya · PPB

TRIZYMAL TABLETS

PROTEINASE LIPASE AMYLASE

14191 PROTEINASE 150 MG LIPASE 100 MG AMYLASE 25 MG alimentary tract and metabolism INN generic

What it does

Amylase is an enzyme that helps break down carbohydrates into sugars, aiding digestion.

Commonly used for: digestive problems, carbohydrate malabsorption

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
14191
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
PROTEINASE LIPASE AMYLASE
Strength
-
Pack size
-
Therapeutic class
-
ATC class (WHO)
A09AA - Enzyme preparations
RxNorm RxCUI
743
Manufacturer / MAH
Njimia Pharmaceuticals
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
PR7J+WM3, Ladhies Rd, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:54:50 · updated 2026-07-26 11:45:22

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About amylase

Amylase is an enzyme that helps break down carbohydrates into sugars, aiding digestion.

What it treats

  • digestive problems
  • carbohydrate malabsorption

How it works

Amylase helps the body digest carbohydrates by converting them into simpler sugars.

Who it's for

People who have difficulty digesting carbohydrates or have conditions affecting digestion.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About lipase

Lipase is an enzyme that helps break down fats in the food we eat, making it easier for the body to absorb nutrients.

What it treats

  • pancreatic insufficiency
  • fat malabsorption syndrome

How it works

Lipase aids in the digestion of dietary fats by breaking them down into smaller molecules that the body can absorb.

Who it's for

Lipase is for people who have difficulty digesting fats due to conditions like pancreatic insufficiency.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About proteinase

Proteinase is an enzyme that helps break down proteins in the body.

What it treats

  • pancreatic insufficiency
  • digestive disorders

How it works

It aids in the digestion of proteins into smaller parts for better absorption.

Who it's for

People with conditions that affect their ability to digest proteins properly.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: amylase

BNF-referenced

Amylase is an enzyme that catalyzes the hydrolysis of starch into sugars. It plays a crucial role in carbohydrate digestion by breaking down complex carbohydrates into simpler sugars, which can then be absorbed by the body. The enzyme is produced primarily in the salivary glands and the pancreas. Amylase can be measured in blood and urine to assess pancreatic function and diagnose conditions such as pancreatitis or salivary gland disorders.

Indications

  • Pancreatitis
  • Salivary gland disorders
  • Carbohydrate malabsorption syndromes

Dosage

Children: Refer to the BNF for Children for appropriate dosing information.

Adults: Refer to the specific guidelines and dosing recommendations in the BNF.

Mechanism of action

Amylase facilitates the breakdown of starch and glycogen into maltose and dextrins by cleaving the α-1,4-glycosidic bonds in these polysaccharides. Its action begins in the mouth with salivary amylase and continues in the small intestine with pancreatic amylase, where it further digests carbohydrates.

Pharmacodynamics

Amylase increases the rate of carbohydrate digestion, thereby influencing blood glucose levels. The enzyme's activity can be affected by pH levels, temperature, and the presence of inhibitors or activators. In clinical settings, elevated levels of amylase in the blood can indicate pancreatitis or other pancreatic disorders.

Pharmacokinetics

Amylase is absorbed and metabolized in the gastrointestinal tract. Its activity is measured through serum levels, with normal ranges indicating proper pancreatic function. The half-life of amylase in the bloodstream can vary based on individual metabolic rates and health conditions.

Pregnancy

Amylase is generally considered safe during pregnancy but should be used under medical supervision.

Breast-feeding

Amylase is excreted in breast milk; it is advisable to consult a healthcare provider before use while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: lipase

Lipase is an enzyme that catalyzes the hydrolysis of lipids, primarily triglycerides, into free fatty acids and glycerol. It plays a crucial role in the digestion and absorption of dietary fats in the gastrointestinal tract. Lipase is produced in the pancreas and is secreted into the small intestine, where it acts upon dietary fats. Deficiencies in lipase can lead to malabsorption of fats and associated nutritional deficiencies.

Indications

  • Pancreatic insufficiency
  • Cystic fibrosis
  • Chronic pancreatitis
  • Malabsorption syndromes

Dosage

Children: Refer to the BNF for Children for specific pediatric dosing guidelines, as it varies based on age, weight, and clinical conditions.

Adults: Refer to specific product guidelines or clinical protocols, as dosages may vary based on the formulation and clinical condition.

Mechanism of action

Lipase hydrolyzes triglycerides into diglycerides and free fatty acids. This process occurs in the presence of bile salts, which emulsify fats, allowing lipase to effectively access and break down lipid molecules. The free fatty acids produced can then be absorbed by the intestinal mucosa and transported into the bloodstream.

Pharmacodynamics

Lipase enhances the digestion of dietary fats, facilitating their absorption. The activity of lipase is pH-dependent, with optimal function occurring in the alkaline environment of the small intestine. The enzyme's activity can be influenced by factors such as dietary composition and the presence of bile salts. Elevated levels of lipase in the bloodstream can indicate pancreatic inflammation or damage, such as in cases of pancreatitis.

Pharmacokinetics

Lipase is not absorbed systemically; it functions locally in the gastrointestinal tract. The enzyme is secreted by the pancreas and acts in the small intestine. Its activity can be affected by gastrointestinal transit time and the presence of other digestive enzymes. The half-life of lipase in the gastrointestinal tract is dependent on dietary intake and gastrointestinal motility.

Adverse effects

  • Abdominal cramping
  • Diarrhea
  • Nausea
  • Vomiting
  • Allergic reactions

Precautions

  • Use with caution in patients with a history of pancreatitis
  • Monitor for signs of allergic reactions
  • Evaluate dietary fat intake in patients receiving lipase therapy

Pregnancy

Lipase is generally considered safe during pregnancy, but should be used under medical supervision.

Breast-feeding

Lipase can be used while breastfeeding, although it is advisable to consult a healthcare provider.

Storage

Store in a cool, dry place, away from direct light. Keep out of reach of children.

Formulations

  • Capsules
  • Tablets
  • Powder for oral suspension

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: proteinase

Proteinases, also known as proteases or peptidases, are a class of enzymes that catalyze the hydrolysis of peptide bonds in proteins, leading to their breakdown into smaller peptides or amino acids. These enzymes play crucial roles in various biological processes, including protein digestion, cell signaling, immune response, and the regulation of metabolic pathways. Proteinases are widely distributed in organisms and are classified into several categories based on their catalytic mechanisms, including serine, cysteine, aspartic, and metalloproteinases.

Indications

  • Digestive disorders due to protein malabsorption
  • Pancreatic insufficiency
  • Inflammatory conditions where proteolytic activity is beneficial
  • Certain types of cancer where proteases are involved in tumor progression

Dosage

Children: Refer to specific clinical guidelines or product information for appropriate dosing as it may vary based on indication and formulation.

Adults: Refer to specific clinical guidelines or product information for appropriate dosing as it may vary based on indication and formulation.

Mechanism of action

Proteinases function by cleaving peptide bonds in proteins, which can lead to the activation or inactivation of certain proteins involved in biological pathways. The mechanism typically involves the formation of a tetrahedral intermediate during the hydrolysis process, which is stabilized by specific amino acid residues at the active site of the enzyme. This enzymatic activity is essential for a variety of physiological processes, such as digestion, cell division, and apoptosis.

Pharmacodynamics

The pharmacodynamics of proteinases involve their interaction with substrates to produce specific physiological effects. The activity of proteinases can influence numerous biological processes, including inflammation, immune responses, and tissue remodeling. Inhibition or dysregulation of proteinase activity can lead to pathological conditions, such as chronic inflammatory diseases, cancer, and cardiovascular disorders.

Pharmacokinetics

The pharmacokinetics of proteinases vary depending on their source and formulation. Generally, proteinases can be administered systemically or locally, where their absorption, distribution, metabolism, and excretion are influenced by factors such as molecular weight, stability, and the presence of inhibitors. Enzymatic activity may be affected by pH levels, temperature, and the presence of cofactors. For therapeutic applications, the route of administration can also impact the bioavailability and efficacy of proteinase treatments.

Pregnancy

Consult a healthcare provider before use; safety during pregnancy not established.

Breast-feeding

Consult a healthcare provider before use; safety during breastfeeding not established.

Storage

Store in a cool, dry place away from direct sunlight. Ensure the container is tightly closed.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: amylase

PubChem CID 71475145

Molecular formula: C11H10FNO

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.